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Edited by Horst FeldmannAbstract Follicular dendritic cells (FDC) play crucial roles in
immune regulation. TNF-a has been shown to be essential to
the FDC network. However, the molecular regulation of FDC
proliferation has not been characterized. Here, we show that
TC1(C8orf4), a novel positive regulator of the Wnt/b-catenin
pathway in vertebrates, is upregulated by IL-1b and TNF-a in
the human FDC-like line HK. TC1 enhances HK cell prolifera-
tion, while TC1-knockdown inhibits the proliferation induced by
IL-1b, suggesting a role of TC1 as a regulator of FDC prolifer-
ation. The regulation by pro-inﬂammatory cytokines suggests
that TC1 might be implicated in linking local inﬂammation to
immune response by stimulating FDC.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Follicular dendritic cells (FDC) play crucial roles in germinal
center formation and B cell diﬀerentiation (reviewed in [1,2]).
FDCs display elaborate cytoplasmic processes [3], which pres-
ent native antigens on the surface in the form of immune-
complexes through Fc receptors and complement receptors.
FDCs organize mature lymphoid follicles collaborating with
B and T cells [1,2,4]. TNF-a has been shown to be essential
to the development of the FDC network in germinal centers
[5,6]. Pro-inﬂammatory cytokines TNF-a and IL-1b activate
IKKs, which target IjB for polyubiquitination and subsequent
degradation by proteasome, thereby releasing NF-jB. The acti-
vation of NF-jB has been widely implicated in regulation of
immunity, inﬂammation, and apoptosis [7–9]. However, it has
remained to be elucidated how NF-jB activation enhances
FDC proliferation.
Recently, we have reported that TC1(C8orf4) functions as a
positive regulator of the Wnt/b-catenin signaling pathway [10]*Corresponding author. Fax: +82 2 472 7898.
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doi:10.1016/j.febslet.2006.05.036that has been widely implicated in regulating cell proliferation
in cancers and development [11–13]. TC1 is a small protein in
vertebrates [14,15], which enhances the signaling pathway by
relieving the antagonistic function of Chibby on b-catenin
mediated transcription [16]. TC1 enhances cancer cell prolifer-
ation [17,18] and invasiveness [18]. The expression of TC1 cor-
related with aggressive biological behavior of gastric cancer
and with poor survival [18]. However, the transcriptional reg-
ulation of TC1 has remained to be investigated.
In this study, we investigated the biological eﬀects of TNF-a
and IL-1b on TC1 expression. Human FDC-like line HK [19]
was used for the investigation because of the crucial roles of
FDCs in the immune system and the requirement of TNF-a
for the proliferation. We were also interested in the potential
biological role of TC1 in non-neoplastic primary culture cells.
Here, we show that IL-1b and TNF-a upregulate TC1
expression in a NF-jB-dependent manner. TC1 upregulated
b-catenin target genes in HK cells as in cancer cells. TC1 en-
hanced the proliferation of HK cells while TC1-knockdown
inhibited the proliferation induced by IL-1b, suggesting a bio-
logical role of TC1 as a major regulator of FDC proliferation.
The regulation of TC1 by pro-inﬂammatory cytokines suggests
that it might be implicated in linking local inﬂammation to B
cell-mediated immune response.2. Materials and methods
2.1. Cells and reagents
FDC-like cell line HK was established from human tonsils and
grown in RPMI 1640 supplemented with 10% fetal bovine serum,
2 mM L-glutamine, and 80 lg/ml gentamicin in a humidiﬁed atmo-
sphere of 5% CO2 at 37 C [19,20]. Experiments were done using
HK cells of 9–13 passages. Human recombinant IL-1b and TNF-a
were purchased commercially (Sigma, St. Louis, MO), and applied
at 20 U/ml media and 10 ng/ml, respectively. Sulindac sulﬁde and
PDTC (pyrrolidine dithiocarbamate) were also purchased (Sigma),
and applied as indicated.
2.2. Plasmids and Lenti-viral constructs
HA-TC1 construct in pcDNA3 vector (Invitrogen, Carldbad, CA)
was described previously [10]. Lenti-TC1, a full length TC1-expressing
lentiviral vector was constructed by inserting TC1 ORF into lentiM1.2
vector (VectorCore A Inc., Deajeon, Korea), which had mCMV pro-
moter for the expression and eGFP-Zeocin fusion protein under IRES
promoter. LentiM1.4-eGFP vector was used as control. Lenti-siTC1,
a shRNA-expression lentiviral vector for targeting TC1 gene, was alsoblished by Elsevier B.V. All rights reserved.
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Fig. 1. (A) TC1 upregulation by IL-1b in HK cells. After the treatment
of 20 U/ml IL-1b, TC1 mRNA levels were measured by SYBR-green
real-time PCR in quadruplicate using b-actin as internal control. The
TC1 expression is enhanced in an hour, reaching more than 10 times of
the basal level in 3 h. (B) TC1 upregulation by IL-1b and TNF-a. TC1
levels were measured at 6 h after the treatment of 20 U/ml IL-1b and/
or 10 ng/ml TNF-a. TNF-a also enhances TC1 but to a lesser degree
than IL-1b does. IL-1b and TNF-a together show a synergistic eﬀect.
3520 Y. Kim et al. / FEBS Letters 580 (2006) 3519–3524constructed by inserting synthetic oligonucleotide, 5 0-CGGAATT-
CACACAGACCAAGAATCACTAGAAAGttcaagagaCTTTCTAGTG-
ATTCTTGGTCTGTGTTTTTTGATATCTAGACA-3 0 (italicized
letters represent sense and antisense sequences of TC1, small letters
represent an insert for loop, and the 5 Ts represent a transcription stop
signal) into the EcoRI–XbaI site of shLenti2.4G vector (VectorCore A
Inc.). The siRNA sequence was previously shown to downregulate
TC1 expression eﬃciently and speciﬁcally [10,18]. The control con-
sisted of scrambled shRNA sequences (5 0-AATCGCATAGCG-
TATGCCGTT-3 0) inserted into the same vector. Lentiviruses were
prepared according to the standard protocol [21].
2.3. Real-time and semiquantitative RT-PCR
TC1 expression levels were measured using real-time PCR analysis.
HK cells were treated with IL-1b, TNF-a, sulindac and/or PDTC as
indicated. Total RNA was extracted using Trizol reagent (Invitrogen)
and cDNA was synthesized using Superscript II reverse transcriptase
(Invitrogen). Quantitative PCR was performed using a continuous
ﬂuorescence detecting thermal cycler ABI PRISM 7000 Sequence
Detection System (ABI, Foster city, CA), and a SYBR Green real-
time PCR master mix (Toyobo, Osaka, Japan). Measurements were
done in triplicate using b-actin gene as an endogenous control. For
the statistical analysis, analysis of variance (ANOVA) test was applied
using the SPSS software (SPSS Inc. Chicago, IL).
The expressions of TC1 and/or b-catenin target genes were analyzed
after Lenti-TC1 or Lenti-siTC1 transfection using corresponding con-
trol vectors and b-actin as loading control. Semiquantitative RT-PCR
was done as described previously [10,22], using primers for TC1, 5 0-
caagccatcatcatgtccac-3 0 and 5 0-gttgcccacggctttcttac-3 0; c-Myc, 5 0-tgctc-
catgaggagacacc-3 0 and 5 0-ctctgaccttttgccaggag-30; c-MET, 5 0-gcatttt-
tacggacccaatc-3 0 and 5 0-gctgcaaagctgtggtaaac-30; Cyclin D1, 5 0-
tcctctccaaaatgccagag-30 and 5 0-ggcggattggaaatgaact-30; and b-actin
5 0-ggcacccagcacaatgaag-30 and 5 0-gccgatccacacggagtact-30.
2.4. Immunoﬂuorescence microscopy
HK cells grown on cover slips were immunostained using rabbit
anti-Rel A antiserum (Santa Cruz Biotechnology, Santa Cruz, CA).
After washing with PBS, FITC-labeled anti-rabbit second antibody
(Jackson Immunoresearch, West Grove, PN) was applied. DNA stain-
ing was done with DAPI (Sigma). Cells were viewed using an Olympus
BX51 ﬂuorescence microscope. For control, the primary antibody was
replaced with normal rabbit sera.
2.5. Cell proliferation assay
The proliferation of HK cells with or without treatment of IL-1b
and/or TNF-a was analyzed using WST-1 proliferation assay kit
according to the manufacturer’s instruction (Roche, Mannheim, Ger-
many). Lenti-TC1 or Lenti-siTC1-transfected HK cells were analyzed
using corresponding controls. Measurements were done in quadrupli-
cate at 24, 48, and 72 h after cytokine treatments, and fold changes in
comparison with controls were analyzed using ANOVA test.3. Results
3.1. IL-1b and TNF-a enhances TC1 expression in HK cells
TC1 expression was at low level in HK cells normally. Upon
IL-1b treatment, TC1 expression was upregulated promptly,
reaching more than 10 times of the basal level in 3 h as mea-
sured by real-time PCR (Fig. 1A). After 24 h, TC1 expression
decreased to remain at a considerably high level compared to
the untreated control. Under the experimental conditions,
IL-1b upregulated TC1 much more than TNF-a did
(Fig. 1B). IL-1b and TNF-a enhanced the proliferation syner-
gistically (P < 0.001).
3.2. IL-1b-induced TC1 upregulation is NF-kB-dependent
The upregulation of TC1 by IL-1b and TNF-a suggested
that TC1 might be a target gene of NF-jB. To test the hypoth-
esis, we then analyzed the eﬀects of IKK inhibitor sulindac [23]and NF-jB inhibitor PDTC [24]. Both sulindac sulﬁde, an ac-
tive metabolite of sulindac, and PDTC were applied at rela-
tively low levels, 50 lM, which did not aﬀect cell growth or
damage (data not shown). After 3 h, TC1 levels were measured
and compared with untreated control. Both sulindac and
PDTC inhibited IL-1b-induced TC1 upregulation signiﬁcantly
(P < 0.001), suggesting that the upregulation was NF-jB-
dependent (Fig. 2). Given the prompt upregulation of TC1
after the cytokine treatments, our data suggested TC1 as one
of direct target genes of NF-jB.
3.3. NF-kB activation by IL-1b in HK cells
It has been shown that TNF-a activates NF-jB in HK cells
[6]. However, the eﬀect of IL-1b on the NF-jB activation has
not been reported in HK cells. Upon the activation by the cyto-
kines, NF-jB is released from IjB to be translocated into the
nucleus [7–9]. Then, NF-jB regulates target genes including
IjB and, thereby, the transcriptional activity of NF-jB is re-
duced again rather rapidly upon the negative feedback by en-
hanced IjB. We analyzed the IL-1b eﬀect using
immunoﬂuorescence staining for Rel A, a subunit of NF-jB.
Upon IL-1b treatment, the nuclear RelA immunostaining
was detected in 30 min, and then decreased mildly after 3 h
(Fig. 3). The nuclear immunostaining largely disappeared in
24 h. Our data showed that IL-1b also activated NF-jB in
HK cells.
Fig. 3. IL-1b induces nuclear translocation of NF-jB activation by in HK cel
Rel A antiserum. After washing with PBS, FITC-labeled anti-rabbit second
were viewed using Olympus BX51 ﬂuorescence microscope.
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Fig. 2. Eﬀect of sulindac and PDTC on IL-1b-induced TC1 upregu-
lation. HK cells were treated with 20 U/ml IL-1b, 50 lM sulindac
sulﬁde, and/or 50 lM PDTC. After 3 h, TC1 levels were measured by
SYBR-green real-time PCR in quadruplicate using b-actin as internal
control. Sulindac and PDTC inhibited TC1 upregulation by IL-1b
in a dose-dependent manner, suggesting an NF-jB-dependent
enhancement.
Y. Kim et al. / FEBS Letters 580 (2006) 3519–3524 35213.4. TC1 upregulates b-catenin target genes in HK cells
Previously, we have shown that TC1 upregulates b-catenin
target genes in cancer cells [10]. Because TC1 expression level
was quite low in HK line, a gain-of-function study by introduc-
ing exogenousTC1would have been appropriate.However, HK
cells are resistant to conventional gene transfer methods (data
not shown).Thus,we constructed the full lengthTC1 in lentiviral
vector to facilitate the gene transfer. HK cells were transfected
with lentiviral constructs eﬀectively so that most cells expressed
GFP in 24 h (data not shown). TC1-transfectedHKcells showed
markedly upregulated TC1 expression in comparison with con-
trol vector-transfected cells as measured by real-time PCR
(Fig. 4A). The expressions of cyclin D1, c-Myc, and c-Met were
enhanced signiﬁcantly compared to the control (Fig. 4B) as
measured by semiquantitative RT-PCR [10]. They are b-catenin
target genes and are implicated in cell proliferation (reviewed in
[25–27]). Our data suggest that TC1 functions as a positive reg-
ulator of the Wnt/b-catenin signaling pathway in HK cells also.ls. HK cells grown on cover slips were immunostained using rabbit anti-
antibody was applied. DNA staining was done using DAPI, and cells
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Fig. 4. TC1 upregulates b-catenin target genes in HK cells. (A) TC1 expression in Lenti-TC1 or control vector-transfected cells. The expression was
measured by real-time PCR in quadruplicate using b-actin as internal control. (B) Semiquantitative RT-PCR for b-catenin target genes cyclin D1, c-
Myc and c-Met in Lenti-TC1-transfected HK cells and control vector-transfected cells. Densitometric values were normalized using b-actin as
loading control.
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The upregulation of cyclin D1, c-Myc, and c-Met suggested
that TC1 might enhance the proliferation of HK cells. We ﬁrst
analyzed the eﬀects of IL-1b and TNF-a on HK cell prolifer-
ation. TNF-a was shown to enhance the proliferation of HK
cells [6]; however, the role of IL-1b has not been reported.
IL-1b and TNF-a showed similar enhancing eﬀects on the pro-
liferation compared to untreated HK cells (P < 0.001,
Fig. 5A). IL-1b and TNF-a together showed a signiﬁcant syn-
ergistic eﬀect (P < 0.001), enhancing the proliferation continu-
ously at a similar rate for 72 h (Fig. 5A).0
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Fig. 5. TC1 and cytokine eﬀects on HK cell proliferation. (A) Eﬀects of IL-1
ml TNF-a was applied to HK cells, and the proliferation was analyzed usin
quadruplicate at 24, 48, and 72 h after cytokine treatments. Fold changes w
proliferation of TC1-Lenti- and control vector-transfected HK cells with or w
siTC1 transfection compared to the control vector-transfected HK cells. TC
internal control. (D) The proliferation of Lenti-siTC1- and control vector-trWe then investigated the eﬀect of TC1 transfection with or
without IL-1b treatment. TC1-transfected cells showed signif-
icant enhancement of proliferation in 72 h compared to the
control vector-transfected cells (P < 0.001, Fig. 5B). The
enhancement by TC1 was higher than that by IL-1b alone in
72 h (P < 0.05). TC1 and IL-1b showed an additive eﬀect on
HK cell proliferation.
To investigate the normal requirements of TC1 in HK cell
proliferation, we next analyzed the eﬀect of TC1 knockdown
on HK cell proliferation. Lenti-siRNA was constructed using
a siRNA sequence that was shown to downregulate TC1con
siTC1
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b and/or TNF-a on HK cell proliferation. 20 U/ml IL-1b and/or 10 ng/
g WST-1 proliferation assay kit (Roche). Measurements were done in
ere analyzed in comparison with controls using ANOVA test. (B) The
ithout IL-1b was measured similarly. (C) TC1 knockdown using Lenti-
1 was measured by real-time PCR in quadruplicate using b-actin as
ansfected HK cells with or without IL-1b was measured similarly.
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downregulated endogenous TC1 signiﬁcantly compared to
the control vector (Fig. 5C). TC1-knockdown inhibited the
proliferation compared to the control vector-transfected cells
(P < 0.001, Fig. 5D). Lenti-siTC1 inhibited the IL-1b-induced
enhancement signiﬁcantly (P < 0.001). Together, our data sug-
gest that TC1 is a major regulator of FDC proliferation, and
the enhancing eﬀect of IL-1b might be TC1-dependent.4. Discussion
The regulation of FDC proliferation is crucial for B-cell
mediated immune response. TNF-a is essential for the devel-
opment of FDC network in the germinal center. However, it
has remained to be elucidated how NF-jB activation by
TNF-a enhances the proliferation of FDCs. Our data suggest
that TC1 might be a NF-jB-dependent regulator of FDC pro-
liferation. The suggested role of TC1 is compatible with the its
proposed function as a positive regulator of the Wnt/b-catenin
pathway.
TC1 was upregulated promptly by IL-1b/TNF-a and was
inhibited by IKK/NF-jB inhibitors, suggesting TC1 as one
of target genes of NF-jB. Both IL-1b and TNF-a activated
NF-jB and enhanced the proliferation of HK cells synergisti-
cally. However, TC1 upregulation by IL-1b was signiﬁcantly
higher than by TNF-a. Together, our data suggest a signiﬁcant
role of IL-1b in FDC regulation.
Both gain- and loss-of-function analyses suggested that TC1
was implicated in the regulation of HK cell proliferation. TC1
is present in vertebrates, and is tightly regulated at both tran-
scriptional and post-translational levels [10]. Nonetheless,
TC1-knockdown downregulated HK cell proliferation and
inhibited IL-1b-induced proliferation signiﬁcantly, suggesting
that TC1 is a major regulator of FDC proliferation. The regu-
lation of TC1 by pro-inﬂammatory cytokines such as IL-1b
and TNF-a suggests that TC1 might be implicated in linking
local inﬂammation to immune response by stimulating FDCs.
HK cells express FDC markers such as HJ2, GP93, 3C8,
8D6, DRC1, and KIM4 (reviewed in [2]). Functionally, HK
cells preferentially bind germinal center B cells, providing them
with survival signals, while the majority of unbound B cells un-
dergo apoptosis promptly. However, functional analyses of
individual genes in FDC-like cells have been restricted, because
they are refractory to gene modulations using conventional
gene transfer methods. Our data showed that lentiviral vectors
could be applied to the functional analysis of genes of interest
in FDC-like cells.
Our data suggest that TC1 might link NF-jB and Wnt/b-
catenin pathways. It has been shown that b-catenin inhibits
NF-jB activity in cancers and intestinal epithelial cells
[28,29]. However, no positive link between the pathways has
been reported so far. The crosstalk might have a signiﬁcant
implication in cancers. Both NF-jB [30] and Wnt/b-catenin
pathways [11–13] have been implicated in various cancers.
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